The global Rheumatic Disorders Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Rheumatic Disorders Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Rheumatic Disorders Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Rheumatic Disorders Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rheumatic Disorders Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Rheumatic Disorders Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Rheumatic Disorders Drug revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Rheumatic Disorders Drug Market Report

Report Metric	Details
Report Name	Rheumatic Disorders Drug Market
CAGR	5%
Segment by Type	Acting on Tumor Necrosis Factor-Alpha Acting on Interleukins and Interleukin Receptors Acting on Protein Kinases Acting on Cell Surface Antigens Acting on Hormones and Hormone Receptors Others
Segment by Application	Rheumatoid Arthritis Osteoarthritis Osteoporosis Systemic Lupus Erythematosus Psoriatic Arthritis Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, Roche, Eli Lilly, Bristol-Myers Squibb
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Rheumatic Disorders Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rheumatic Disorders Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rheumatic Disorders Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Rheumatic Disorders Drug Market report?

Ans: The main players in the Rheumatic Disorders Drug Market are AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, Roche, Eli Lilly, Bristol-Myers Squibb

What are the Application segmentation covered in the Rheumatic Disorders Drug Market report?

Ans: The Applications covered in the Rheumatic Disorders Drug Market report are Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Systemic Lupus Erythematosus, Psoriatic Arthritis, Others

What are the Type segmentation covered in the Rheumatic Disorders Drug Market report?

Ans: The Types covered in the Rheumatic Disorders Drug Market report are Acting on Tumor Necrosis Factor-Alpha, Acting on Interleukins and Interleukin Receptors, Acting on Protein Kinases, Acting on Cell Surface Antigens, Acting on Hormones and Hormone Receptors, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rheumatic Disorders Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Acting on Tumor Necrosis Factor-Alpha

1.2.3 Acting on Interleukins and Interleukin Receptors

1.2.4 Acting on Protein Kinases

1.2.5 Acting on Cell Surface Antigens

1.2.6 Acting on Hormones and Hormone Receptors

1.2.7 Others

1.3 Market by Application

1.3.1 Global Rheumatic Disorders Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Rheumatoid Arthritis

1.3.3 Osteoarthritis

1.3.4 Osteoporosis

1.3.5 Systemic Lupus Erythematosus

1.3.6 Psoriatic Arthritis

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Rheumatic Disorders Drug Market Perspective (2019-2030)

2.2 Global Rheumatic Disorders Drug Growth Trends by Region

2.2.1 Rheumatic Disorders Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Rheumatic Disorders Drug Historic Market Size by Region (2019-2024)

2.2.3 Rheumatic Disorders Drug Forecasted Market Size by Region (2025-2030)

2.3 Rheumatic Disorders Drug Market Dynamics

2.3.1 Rheumatic Disorders Drug Industry Trends

2.3.2 Rheumatic Disorders Drug Market Drivers

2.3.3 Rheumatic Disorders Drug Market Challenges

2.3.4 Rheumatic Disorders Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Rheumatic Disorders Drug by Players

3.1.1 Global Rheumatic Disorders Drug Revenue by Players (2019-2024)

3.1.2 Global Rheumatic Disorders Drug Revenue Market Share by Players (2019-2024)

3.2 Global Rheumatic Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Rheumatic Disorders Drug, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Rheumatic Disorders Drug Market Concentration Ratio

3.4.1 Global Rheumatic Disorders Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rheumatic Disorders Drug Revenue in 2023

3.5 Global Key Players of Rheumatic Disorders Drug Head office and Area Served

3.6 Global Key Players of Rheumatic Disorders Drug, Product and Application

3.7 Global Key Players of Rheumatic Disorders Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Rheumatic Disorders Drug Breakdown Data by Type

4.1 Global Rheumatic Disorders Drug Historic Market Size by Type (2019-2024)

4.2 Global Rheumatic Disorders Drug Forecasted Market Size by Type (2025-2030)

5 Rheumatic Disorders Drug Breakdown Data by Application

5.1 Global Rheumatic Disorders Drug Historic Market Size by Application (2019-2024)

5.2 Global Rheumatic Disorders Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Rheumatic Disorders Drug Market Size (2019-2030)

6.2 North America Rheumatic Disorders Drug Market Size by Type

6.2.1 North America Rheumatic Disorders Drug Market Size by Type (2019-2024)

6.2.2 North America Rheumatic Disorders Drug Market Size by Type (2025-2030)

6.2.3 North America Rheumatic Disorders Drug Market Share by Type (2019-2030)

6.3 North America Rheumatic Disorders Drug Market Size by Application

6.3.1 North America Rheumatic Disorders Drug Market Size by Application (2019-2024)

6.3.2 North America Rheumatic Disorders Drug Market Size by Application (2025-2030)

6.3.3 North America Rheumatic Disorders Drug Market Share by Application (2019-2030)

6.4 North America Rheumatic Disorders Drug Market Size by Country

6.4.1 North America Rheumatic Disorders Drug Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Rheumatic Disorders Drug Market Size by Country (2019-2024)

6.4.3 North America Rheumatic Disorders Drug Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Rheumatic Disorders Drug Market Size (2019-2030)

7.2 Europe Rheumatic Disorders Drug Market Size by Type

7.2.1 Europe Rheumatic Disorders Drug Market Size by Type (2019-2024)

7.2.2 Europe Rheumatic Disorders Drug Market Size by Type (2025-2030)

7.2.3 Europe Rheumatic Disorders Drug Market Share by Type (2019-2030)

7.3 Europe Rheumatic Disorders Drug Market Size by Application

7.3.1 Europe Rheumatic Disorders Drug Market Size by Application (2019-2024)

7.3.2 Europe Rheumatic Disorders Drug Market Size by Application (2025-2030)

7.3.3 Europe Rheumatic Disorders Drug Market Share by Application (2019-2030)

7.4 Europe Rheumatic Disorders Drug Market Size by Country

7.4.1 Europe Rheumatic Disorders Drug Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Rheumatic Disorders Drug Market Size by Country (2019-2024)

7.4.3 Europe Rheumatic Disorders Drug Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Rheumatic Disorders Drug Market Size (2019-2030)

8.2 China Rheumatic Disorders Drug Market Size by Type

8.2.1 China Rheumatic Disorders Drug Market Size by Type (2019-2024)

8.2.2 China Rheumatic Disorders Drug Market Size by Type (2025-2030)

8.2.3 China Rheumatic Disorders Drug Market Share by Type (2019-2030)

8.3 China Rheumatic Disorders Drug Market Size by Application

8.3.1 China Rheumatic Disorders Drug Market Size by Application (2019-2024)

8.3.2 China Rheumatic Disorders Drug Market Size by Application (2025-2030)

8.3.3 China Rheumatic Disorders Drug Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Rheumatic Disorders Drug Market Size (2019-2030)

9.2 Asia Rheumatic Disorders Drug Market Size by Type

9.2.1 Asia Rheumatic Disorders Drug Market Size by Type (2019-2024)

9.2.2 Asia Rheumatic Disorders Drug Market Size by Type (2025-2030)

9.2.3 Asia Rheumatic Disorders Drug Market Share by Type (2019-2030)

9.3 Asia Rheumatic Disorders Drug Market Size by Application

9.3.1 Asia Rheumatic Disorders Drug Market Size by Application (2019-2024)

9.3.2 Asia Rheumatic Disorders Drug Market Size by Application (2025-2030)

9.3.3 Asia Rheumatic Disorders Drug Market Share by Application (2019-2030)

9.4 Asia Rheumatic Disorders Drug Market Size by Region

9.4.1 Asia Rheumatic Disorders Drug Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Rheumatic Disorders Drug Market Size by Region (2019-2024)

9.4.3 Asia Rheumatic Disorders Drug Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Type

10.2.1 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Application

10.3.1 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Country

10.4.1 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Rheumatic Disorders Drug Introduction

11.1.4 AbbVie Revenue in Rheumatic Disorders Drug Business (2019-2024)

11.1.5 AbbVie Recent Developments

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Rheumatic Disorders Drug Introduction

11.2.4 Amgen Revenue in Rheumatic Disorders Drug Business (2019-2024)

11.2.5 Amgen Recent Developments

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Rheumatic Disorders Drug Introduction

11.3.4 Johnson & Johnson Revenue in Rheumatic Disorders Drug Business (2019-2024)

11.3.5 Johnson & Johnson Recent Developments

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Rheumatic Disorders Drug Introduction

11.4.4 Novartis Revenue in Rheumatic Disorders Drug Business (2019-2024)

11.4.5 Novartis Recent Developments

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Rheumatic Disorders Drug Introduction

11.5.4 Pfizer Revenue in Rheumatic Disorders Drug Business (2019-2024)

11.5.5 Pfizer Recent Developments

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Rheumatic Disorders Drug Introduction

11.6.4 Roche Revenue in Rheumatic Disorders Drug Business (2019-2024)

11.6.5 Roche Recent Developments

11.7 Eli Lilly

11.7.1 Eli Lilly Company Details

11.7.2 Eli Lilly Business Overview

11.7.3 Eli Lilly Rheumatic Disorders Drug Introduction

11.7.4 Eli Lilly Revenue in Rheumatic Disorders Drug Business (2019-2024)

11.7.5 Eli Lilly Recent Developments

11.8 Bristol-Myers Squibb

11.8.1 Bristol-Myers Squibb Company Details

11.8.2 Bristol-Myers Squibb Business Overview

11.8.3 Bristol-Myers Squibb Rheumatic Disorders Drug Introduction

11.8.4 Bristol-Myers Squibb Revenue in Rheumatic Disorders Drug Business (2019-2024)

11.8.5 Bristol-Myers Squibb Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Rheumatic Disorders Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Acting on Tumor Necrosis Factor-Alpha

Table 3. Key Players of Acting on Interleukins and Interleukin Receptors

Table 4. Key Players of Acting on Protein Kinases

Table 5. Key Players of Acting on Cell Surface Antigens

Table 6. Key Players of Acting on Hormones and Hormone Receptors

Table 7. Key Players of Others

Table 8. Global Rheumatic Disorders Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 9. Global Rheumatic Disorders Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Rheumatic Disorders Drug Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Rheumatic Disorders Drug Market Share by Region (2019-2024)

Table 12. Global Rheumatic Disorders Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Rheumatic Disorders Drug Market Share by Region (2025-2030)

Table 14. Rheumatic Disorders Drug Market Trends

Table 15. Rheumatic Disorders Drug Market Drivers

Table 16. Rheumatic Disorders Drug Market Challenges

Table 17. Rheumatic Disorders Drug Market Restraints

Table 18. Global Rheumatic Disorders Drug Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Rheumatic Disorders Drug Revenue Share by Players (2019-2024)

Table 20. Global Top Rheumatic Disorders Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatic Disorders Drug as of 2023)

Table 21. Global Rheumatic Disorders Drug Industry Ranking 2022 VS 2023 VS 2024

Table 22. Global 5 Largest Players Market Share by Rheumatic Disorders Drug Revenue (CR5 and HHI) & (2019-2024)

Table 23. Global Key Players of Rheumatic Disorders Drug, Headquarters and Area Served

Table 24. Global Key Players of Rheumatic Disorders Drug, Product and Application

Table 25. Global Key Players of Rheumatic Disorders Drug, Product and Application

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Rheumatic Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Rheumatic Disorders Drug Revenue Market Share by Type (2019-2024)

Table 29. Global Rheumatic Disorders Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Rheumatic Disorders Drug Revenue Market Share by Type (2025-2030)

Table 31. Global Rheumatic Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Rheumatic Disorders Drug Revenue Share by Application (2019-2024)

Table 33. Global Rheumatic Disorders Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Rheumatic Disorders Drug Revenue Share by Application (2025-2030)

Table 35. North America Rheumatic Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 36. North America Rheumatic Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 37. North America Rheumatic Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 38. North America Rheumatic Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 39. North America Rheumatic Disorders Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. North America Rheumatic Disorders Drug Market Size by Country (2019-2024) & (US$ Million)

Table 41. North America Rheumatic Disorders Drug Market Size by Country (2025-2030) & (US$ Million)

Table 42. Europe Rheumatic Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 43. Europe Rheumatic Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 44. Europe Rheumatic Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 45. Europe Rheumatic Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 46. Europe Rheumatic Disorders Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Europe Rheumatic Disorders Drug Market Size by Country (2019-2024) & (US$ Million)

Table 48. Europe Rheumatic Disorders Drug Market Size by Country (2025-2030) & (US$ Million)

Table 49. China Rheumatic Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 50. China Rheumatic Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 51. China Rheumatic Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 52. China Rheumatic Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Rheumatic Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 54. Asia Rheumatic Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 55. Asia Rheumatic Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 56. Asia Rheumatic Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 57. Asia Rheumatic Disorders Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 58. Asia Rheumatic Disorders Drug Market Size by Region (2019-2024) & (US$ Million)

Table 59. Asia Rheumatic Disorders Drug Market Size by Region (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Rheumatic Disorders Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 65. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Country (2019-2024) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size by Country (2025-2030) & (US$ Million)

Table 67. AbbVie Company Details

Table 68. AbbVie Business Overview

Table 69. AbbVie Rheumatic Disorders Drug Product

Table 70. AbbVie Revenue in Rheumatic Disorders Drug Business (2019-2024) & (US$ Million)

Table 71. AbbVie Recent Developments

Table 72. Amgen Company Details

Table 73. Amgen Business Overview

Table 74. Amgen Rheumatic Disorders Drug Product

Table 75. Amgen Revenue in Rheumatic Disorders Drug Business (2019-2024) & (US$ Million)

Table 76. Amgen Recent Developments

Table 77. Johnson & Johnson Company Details

Table 78. Johnson & Johnson Business Overview

Table 79. Johnson & Johnson Rheumatic Disorders Drug Product

Table 80. Johnson & Johnson Revenue in Rheumatic Disorders Drug Business (2019-2024) & (US$ Million)

Table 81. Johnson & Johnson Recent Developments

Table 82. Novartis Company Details

Table 83. Novartis Business Overview

Table 84. Novartis Rheumatic Disorders Drug Product

Table 85. Novartis Revenue in Rheumatic Disorders Drug Business (2019-2024) & (US$ Million)

Table 86. Novartis Recent Developments

Table 87. Pfizer Company Details

Table 88. Pfizer Business Overview

Table 89. Pfizer Rheumatic Disorders Drug Product

Table 90. Pfizer Revenue in Rheumatic Disorders Drug Business (2019-2024) & (US$ Million)

Table 91. Pfizer Recent Developments

Table 92. Roche Company Details

Table 93. Roche Business Overview

Table 94. Roche Rheumatic Disorders Drug Product

Table 95. Roche Revenue in Rheumatic Disorders Drug Business (2019-2024) & (US$ Million)

Table 96. Roche Recent Developments

Table 97. Eli Lilly Company Details

Table 98. Eli Lilly Business Overview

Table 99. Eli Lilly Rheumatic Disorders Drug Product

Table 100. Eli Lilly Revenue in Rheumatic Disorders Drug Business (2019-2024) & (US$ Million)

Table 101. Eli Lilly Recent Developments

Table 102. Bristol-Myers Squibb Company Details

Table 103. Bristol-Myers Squibb Business Overview

Table 104. Bristol-Myers Squibb Rheumatic Disorders Drug Product

Table 105. Bristol-Myers Squibb Revenue in Rheumatic Disorders Drug Business (2019-2024) & (US$ Million)

Table 106. Bristol-Myers Squibb Recent Developments

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Rheumatic Disorders Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Rheumatic Disorders Drug Market Share by Type: 2023 VS 2030

Figure 3. Acting on Tumor Necrosis Factor-Alpha Features

Figure 4. Acting on Interleukins and Interleukin Receptors Features

Figure 5. Acting on Protein Kinases Features

Figure 6. Acting on Cell Surface Antigens Features

Figure 7. Acting on Hormones and Hormone Receptors Features

Figure 8. Others Features

Figure 9. Global Rheumatic Disorders Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Rheumatic Disorders Drug Market Share by Application: 2023 VS 2030

Figure 11. Rheumatoid Arthritis Case Studies

Figure 12. Osteoarthritis Case Studies

Figure 13. Osteoporosis Case Studies

Figure 14. Systemic Lupus Erythematosus Case Studies

Figure 15. Psoriatic Arthritis Case Studies

Figure 16. Others Case Studies

Figure 17. Rheumatic Disorders Drug Report Years Considered

Figure 18. Global Rheumatic Disorders Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Rheumatic Disorders Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Rheumatic Disorders Drug Market Share by Region: 2023 VS 2030

Figure 21. Global Rheumatic Disorders Drug Market Share by Players in 2023

Figure 22. Global Top Rheumatic Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatic Disorders Drug as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Rheumatic Disorders Drug Revenue in 2023

Figure 24. North America Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Rheumatic Disorders Drug Market Share by Type (2019-2030)

Figure 26. North America Rheumatic Disorders Drug Market Share by Application (2019-2030)

Figure 27. North America Rheumatic Disorders Drug Market Share by Country (2019-2030)

Figure 28. United States Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Canada Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Europe Rheumatic Disorders Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 31. Europe Rheumatic Disorders Drug Market Share by Type (2019-2030)

Figure 32. Europe Rheumatic Disorders Drug Market Share by Application (2019-2030)

Figure 33. Europe Rheumatic Disorders Drug Market Share by Country (2019-2030)

Figure 34. Germany Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. France Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. U.K. Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Italy Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Russia Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Nordic Countries Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. China Rheumatic Disorders Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 41. China Rheumatic Disorders Drug Market Share by Type (2019-2030)

Figure 42. China Rheumatic Disorders Drug Market Share by Application (2019-2030)

Figure 43. Asia Rheumatic Disorders Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 44. Asia Rheumatic Disorders Drug Market Share by Type (2019-2030)

Figure 45. Asia Rheumatic Disorders Drug Market Share by Application (2019-2030)

Figure 46. Asia Rheumatic Disorders Drug Market Share by Region (2019-2030)

Figure 47. Japan Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. South Korea Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. China Taiwan Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Southeast Asia Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. India Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Australia Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 54. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Share by Type (2019-2030)

Figure 55. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Share by Application (2019-2030)

Figure 56. Middle East, Africa, and Latin America Rheumatic Disorders Drug Market Share by Country (2019-2030)

Figure 57. Brazil Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Mexico Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Turkey Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Saudi Arabia Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Israel Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 62. GCC Countries Rheumatic Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 63. AbbVie Revenue Growth Rate in Rheumatic Disorders Drug Business (2019-2024)

Figure 64. Amgen Revenue Growth Rate in Rheumatic Disorders Drug Business (2019-2024)

Figure 65. Johnson & Johnson Revenue Growth Rate in Rheumatic Disorders Drug Business (2019-2024)

Figure 66. Novartis Revenue Growth Rate in Rheumatic Disorders Drug Business (2019-2024)

Figure 67. Pfizer Revenue Growth Rate in Rheumatic Disorders Drug Business (2019-2024)

Figure 68. Roche Revenue Growth Rate in Rheumatic Disorders Drug Business (2019-2024)

Figure 69. Eli Lilly Revenue Growth Rate in Rheumatic Disorders Drug Business (2019-2024)

Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Rheumatic Disorders Drug Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Rheumatic Disorders Drug Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-34K5776

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Rheumatoid Arthritis Diagnostic Device Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-0S6275

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Juvenile Idiopathic Arthritis Treatment Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-21W1178

Fri Dec 20 00:00:00 UTC 2024

Add to Cart

Global Viscosupplementation Treatment for Arthritis Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-32P537

Tue Dec 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions